Evgen Pharma (EVG) News Today GBX 0.80 0.00 (0.00%) (As of 04/25/2024) Add Compare Share Share Headlines Stock AnalysisHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period TheraCryf Reports Positive SFX-01 Study ResultsNovember 11, 2024 | markets.businessinsider.comPassing of Dr Sue Foden, ChairNovember 6, 2024 | lse.co.ukPROTAC Market is Expected to Showcase Significant Growth During the Study Period (2020–2034) | DelveInsightAugust 12, 2024 | finance.yahoo.comGlobal Cancer Supportive Care Drugs Market to Cross 17 Billion Mark by 2030| DelveInsightAugust 1, 2024 | finance.yahoo.comEvgen Pharma plc (LON:EVG) Insider Acquires £10,000 in StockApril 6, 2024 | insidertrades.comTRADING UPDATES: Northcoders launches bootcamp; Schroder investsApril 4, 2024 | lse.co.ukEvgen to Raise Up to $2.4 Mln; to Change Name After Acquiring Chronos TherapeuticsMarch 20, 2024 | marketwatch.comEvgen Pharma finds evidence of SFX-01 activity in colon cancer modelsFebruary 27, 2024 | lse.co.ukPharma middlemen face govt. scrutiny over generic drug shortagesFebruary 14, 2024 | msn.comEvgen Pharma Share ChatJanuary 26, 2024 | lse.co.ukMetastatic HR+/HER2− Breast Cancer Market is Expected to Showcase a Significant Growth at a CAGR of 9.3% by 2032, Predicts DelveInsightDecember 4, 2023 | finance.yahoo.comEvgen Pharma "delighted" with cash position after promising first halfOctober 31, 2023 | finance.yahoo.comEvgen Pharma hires interim CFO from Faron, chair to retire this monthSeptember 5, 2023 | lse.co.ukEvgen Pharma Chair Barry Clare Steps Down; Appoints New Interim Chair, Interim CFOSeptember 5, 2023 | marketwatch.comEvgen Pharma Shares Rise on Positive SFX-01 Tablet ReportAugust 15, 2023 | marketwatch.comEvgen Pharma Shares Fall on Ending of License DealAugust 2, 2023 | marketwatch.comEvgen collaborator receives grant from KWF Dutch Cancer SocietyJune 19, 2023 | lse.co.ukEvgen Pharma confident amid Stalicla deal; CFO Moulson to retireJune 7, 2023 | lse.co.ukEvgen Pharma Results From SFX-01 Tablet Trial Meet ExpectationsMarch 22, 2023 | marketwatch.comEvgen Pharma Shares Rise on Drug Candidate DataMarch 16, 2023 | marketwatch.comTHG and musicMagpie move to reassure investors as Silicon Valley Bank's UK arm is sold to HSBCMarch 13, 2023 | msn.comEvgen Pharma starts clinical trial of new SFX-01 tabletNovember 16, 2022 | lse.co.ukCORRECT: Coral Products buys Ecodeck; Evgen Pharma recruitsOctober 13, 2022 | lse.co.ukTRADING UPDATES: Coral Products buys Ecodeck; Evgen Pharma recruitsOctober 12, 2022 | lse.co.ukAIM WINNERS & LOSERS: Europa Oil, i3 Energy slide as well disappointsOctober 11, 2022 | lse.co.ukCompanies Like Evgen Pharma (LON:EVG) Are In A Position To Invest In GrowthOctober 11, 2022 | finance.yahoo.comMarket movers: Electricity generators fall on revenue cap reportsOctober 10, 2022 | proactiveinvestors.com.auShares in drug maker more then double after agreeing $160m dealOctober 10, 2022 | msn.comSTALICLA to in-license SFX-01 from Evgen for neurodevelopment disorder indicationsOctober 10, 2022 | benzinga.comEvgen Pharma Shares Jump After Securing Licensing Deal for Up to $160.5 MlnOctober 10, 2022 | marketwatch.comEvgen Pharma plc (EVG.L)August 16, 2022 | uk.finance.yahoo.comEvegen Pharma and Michigan University to collaborate in colorectal cancer studyJune 13, 2022 | proactiveinvestors.comEvgen Pharma starts trial to test breast cancer tablet; loss narrowsJune 8, 2022 | lse.co.ukEvgen Pharma Drops on FY 2022 Pretax LossJune 8, 2022 | marketwatch.comEvgen Pharma launches new collaboration for lead assetMay 25, 2022 | proactiveinvestors.comEvgen Pharma expanding its work with the Manchester Breast CentreMarch 7, 2022 | proactiveinvestors.com.auEvgen Pharma Shares Rise on Licensing Deal for Sulforaphane AnaloguesJanuary 19, 2022 | marketwatch.comEvgen signs agreement for Spanish institutions' sulfoaphane analoguesJanuary 18, 2022 | lse.co.ukWe're Not Very Worried About Evgen Pharma's (LON:EVG) Cash Burn RateSeptember 27, 2021 | finance.yahoo.comEvgen Pharma Climbs on FDA Orphan-Drug Designation for Brain Tumor TreatmentSeptember 2, 2021 | morningstar.comEvgen Pharma PLC (EVG)August 13, 2021 | investing.com Get Evgen Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EVG and its competitors with MarketBeat's FREE daily newsletter. Email Address Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. EVG Media Mentions By Week EVG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVG News Sentiment▼0.000.47▲Average Medical News Sentiment EVG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVG Articles This Week▼00▲EVG Articles Average Week Get Evgen Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EVG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Glenveagh Properties News Today Minoan Group News Today Unite Group News Today B&M European Value Retail News Today Premier Foods News Today TR Property Investment Trust News Today Baillie Gifford US Growth News Today IG Design Group News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:EVG) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evgen Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Evgen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
